Category: General

State Contract Pharmacy Lawsuit Weekly Roundup: 5th Circuit Appeals and Updates in Arkansas, Minnesota, West Virginia

September 12, 2024 340B Report Staff Views

Key filings and orders occurred in lawsuits challenging the 340B contract pharmacy access law in Missouri.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

ACA Played Key Role in 340B Growth, Drug Industry Consulting Firm Finds

September 12, 2024 Bella Czajkowski, National Correspondent Views

An IQVIA analysis looked at the 340B program’s growth under the Affordable Care Act.

The 340B program has outgrown patient demands and requires additional restrictions and oversight, according to a new report from a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHA Calls on Congress to Defend 340B Access to Specialty, Community Pharmacies Amid Drugmaker Resistance

September 10, 2024 Bella Czajkowski, National Correspondent Views

AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

Specialty and community pharmacies play an essential role in the 340B program and must be protected against interference by drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Pharma-Linked Watchdog Advocacy Group Leader Pens Op-Ed Urging Congress to Advance 340B Legislation

September 10, 2024 Shannon Young, Associate Editor/Senior Writer Views

Tom Schatz, the president of CCAGW and CAGW, urged Congress to "swiftly consider and enact legislation to reform the 340B program” in a Sept. 8 op-ed.

The head of Council for Citizens Against Government Waste (CCAGW)—the lobbying arm of a watchdog group which has long advocated [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Experts Forecast Impact of November Elections on 340B Program, Drug Pricing and the Larger Economy

September 6, 2024 Bella Czajkowski, National Correspondent Views

340B Report hosted a subscriber-only webinar on the 2024 elections on Sept. 5.

November will bring an epic battle for both the U.S. presidency and control in Congress, both of which could have [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Bayer to Extend Contract Pharmacy Restrictions to Federal Grantees, Providers and Advocates Voice Concerns About Recent Trend

September 4, 2024 Shannon Young, Associate Editor/Senior Writer Views

Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy as of Oct. 1.

German drugmaker Bayer will no longer exempt federal grantees from its 340B contract pharmacy policy beginning Oct. 1—the same day [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Analysis Finds Growing Private Equity, Corporate Investments in 340B; Firm Conducting Study Fails to Mention Its Own PE Funding

August 29, 2024 Shannon Young, Associate Editor/Senior Writer Views

A new Berkeley Research Group issue brief looked at trends in 340B investments.

The 340B program’s growth in recent decades has helped it attract a growing number of corporate and private equity investments, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sanofi Asks 340B Hospitals for Information on Purchases of Its Top-Selling Drug

August 22, 2024 Shannon Young, Associate Editor/Senior Writer Views

Sanofi is reportedly asking hospitals for data relating to 340B purchases of Dupixent.

French drugmaker Sanofi has reportedly asked some hospitals for data relating to 340B purchases of a popular drug used to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Industry-funded Think Tank Raises Questions About 340B Hospitals’ Charity Care

August 22, 2024 Shannon Young, Associate Editor/Senior Writer Views

The Pioneer Institute for Public Policy Research compared 29 financially strong 340B hospitals/health systems’ performance on charity care in an Aug. 19 brief.

More transparency surrounding 340B hospital operations is needed to ensure drug discount savings are being used to improve patient care, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AHA Raises ‘Serious Concerns’ with MedPAC’s Direction on 340B

August 20, 2024 Shannon Young, Associate Editor/Senior Writer Views

AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

A major hospital advocacy group recently urged congressional advisers to “carefully consider” the potential negative consequences of any new efforts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live